Broker Regulation

After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of artificially inflating insulin prices.

The DOGE team's request is part of a plan to cut federal spending by $1 trillion, with Medicaid cuts likely.

In this interview, we discuss fiduciary responsibilities, PBM contracts, and litigation risks with two industry experts.

A shift away from the status quo can be scary, but with pharmacy costs and health care spending nearing unsustainable levels and all-time highs and great scrutiny of the fiduciary obligations of plan sponsors, the stakes are too high to hope for better communication, collaboration, and results from traditional PBMs.

Brokers have a critical role to play in helping people practitioners implement solutions that not only address immediate cost concerns but also foster a culture of long-term employee wellbeing.

A surgeon who had to take an urgent call in the middle of a procedure to answer an insurance coverage question is facing legal repercussions after posting about her experience on social media.